Soligenix Inc. (SNGX) |
|
3.34 0.04 (1.21%)
|
02-20 16:00 |
|
Open: |
3.35 |
Pre. Close: |
3.3 |
|
High:
|
3.54 |
Low:
|
3.12 |
|
Volume:
|
892,613 |
Market Cap:
|
69M |
|
|
|
|
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.544 - 3.558 |
3.558 - 3.568 |
|
Low:
|
3.088 - 3.103 |
3.103 - 3.115 |
|
Close:
|
3.316 - 3.341 |
3.341 - 3.36 |
|
Technical analysis |
as of: 2020-02-20 4:43:49 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 4.13  One year: 4.83 |
| Support: |
Support1: 2.35 Support2: 1.61 |
| Resistance: |
Resistance1: 3.54 Resistance2: 4.13 |
| Pivot: |
2.77 |
| Moving Average: |
MA(5): 2.98 MA(20): 2.80
MA(100): 1.51 MA(250): 1.14 |
| MACD: |
MACD(12,26): 0.27 Signal(9): 0.26 |
| Stochastic oscillator: |
%K(14,3): 76.17 %D(3): 66.85 |
| RSI: |
RSI(14): 74.35 |
| 52-week: |
High: 3.54 Low: 0.65 Change(%): 271.1 |
| Average Vol(K): |
3-Month: 37766 10-Days: 43169 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.SNGX has closed above the upper band by 11.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 86.4% wider than normal. The large width of the bands suggest high volatility as compared to SNGX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-02-21
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Arcus Biosciences Inc (NYSE: RCUS ) BELLUS Health Inc (NASDAQ: BLU ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Masimo Corporation (NASDAQ: MASI ) (announced its fourth-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Relmada Therapeutics Inc (NASDAQ: RLMD ) Repro-Med Systems, Inc. (NASDAQ: KRMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) (announced $287.5-million debt offering) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Feb. 13) Scpharmaceuticals Inc (NASDAQ: SCPH ) Soligenix, Inc.
2020-02-20
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
20.65 |
| Shares Float (M) |
16.62 |
|
% Held by Insiders
|
6.98 |
|
% Held by Institutions
|
22.22 |
|
Shares Short (K)
|
34 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.516 |
|
Book Value (p.s.)
|
0.130 |
|
PEG Ratio
|
-5.79 |
|
Profit Margin
|
-193.34 |
|
Operating Margin
|
-209.47 |
|
Return on Assets (ttm)
|
-60.1 |
|
Return on Equity (ttm)
|
-160.5 |
|
Qtrly Rev. Growth
|
-9.2 |
|
Gross Profit (p.s.)
|
0.031 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.501 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-7.54 |
|
Levered Free Cash Flow (M)
|
-4.50 |
Stock Valuations |
|
P/E
|
-6.47 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
25.69 |
|
P/S
|
12.37 |
|
P/CF
|
-9.15 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2016-10-06 |
|
Last Split Ratio
|
0.1 |
|
7 Binary Options
|
|
Your Ad Here
|
|
